Former SignalFire investor Sahir Raoof raises $27.5M for new fund targeting AI in pharma
Proximal Ventures raises debut fund to back startups bringing AI to drug development
Former SignalFire investor Sahir Raoof raises $27.5M for new fund targeting AI in pharma
Key Takeaways
- Proximal Ventures raises debut fund to back startups bringing AI to drug development.
- Former SignalFire investor Sahir Raoof raises $27.5M for new fund targeting AI in pharma Former SignalFire investor Sahir Raoof raises $27.5M for new fund targeting AI in pharma
Read Complete Original Article
Published originally on TechCrunch





